News Snapshot:
SHANGHAI, July 11 (Xinhua) -- A Chinese mainland company has signed agreements with Taiwan enterprises and a foundation on COVID-19 vaccine sales, according to an announcement the company released Sunday. A subsidiary of Shanghai-based Fosun Pharmaceutical Group Co. Ltd. will sell 10 million doses of mRNA COVID-19 vaccines to Taiwan Semiconductor Manufacturing Co., Ltd., Hon Hai Precision Industry Co., Ltd., and Yonglin Charity Foundation, according to the announcement. In March 2020, Fosun inked an agreement with German company BioNTech for the research and development of mRNA vaccines and the exclusive commercial rights and interests on the Chinese mainland and in...
